---
$id: https://graph.org.ai/products/commodity/51151531
$type: Product
source: UNSPSC
code: "51151531"
title: "Zifrosilone"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zifrosilone

**UNSPSC Code**: 51151531
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an acetylcholinesterase inhibitor with the molecular formula C11H13F3OSi, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6275788O83, chemically known as 2,2,2-trifluoro-3-(trimethylsilyl)acetophenone but generally known as zifrosilone, which bears US NIH Compound Identifier 60811. European Medicines Agency schedules Zifrosilone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00154MIG. The term ZIFROSILONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). ZIFROSILONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, ZIFROSILONE remains the US FDA Preferred Term for this commodity. Zifrosilone bears US NLM identifiers UMLS ID C0288321 and NCI Concept Code C82222. SMILES: C[SI](C)(C)C1=CC=CC(=C1)C(=O)C(F)(F)F.

